Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
JELD-WEN Holding
JELD
$167M
| $7.22M | ﹤0.01% |
183,474
-308,178
| -63% | -$11.4M |
|
|
HOUS
1927
DELISTED
Anywhere Real Estate
HOUS
| $7.22M | ﹤0.01% |
+272,422
| New | +$7.9M |
|
1928
Ionis Pharmaceuticals
IONS
$9.51B
| $7.22M | ﹤0.01% |
+143,458
| New | +$7.87M |
|
1929
CALL
Stryker
SYK
$130B
| $7.22M | ﹤0.01% |
46,600
-9,000
| -16% | -$1.37M |
|
1930
J.M. Smucker
SJM
$13B
| $7.21M | ﹤0.01% |
58,038
-164,481
| -74% | -$18.3M |
|
1931
PUT
Aon
AON
$75.5B
| $7.21M | ﹤0.01% |
53,800
+43,500
| +422% | +$6.19M |
|
|
CONN
1932
DELISTED
Conn's Inc.
CONN
| $7.21M | ﹤0.01% |
202,789
+158,204
| +355% | +$4.84M |
|
|
CSGS
1933
DELISTED
CSG Systems International
CSGS
| $7.19M | ﹤0.01% |
164,147
-65,827
| -29% | -$2.84M |
|
1934
PUT
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.36B
| $7.18M | ﹤0.01% |
162,000
-29,800
| -16% | -$1.25M |
|
1935
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
| $7.18M | ﹤0.01% |
267,954
+35,563
| +15% | +$937K |
|
|
AIV
1936
Aimco
AIV
$383M
| $7.17M | ﹤0.01% |
1,230,838
+648,047
| +111% | +$3.82M |
|
1937
Merit Medical Systems
MMSI
$5.42B
| $7.17M | ﹤0.01% |
165,889
+17,785
| +12% | +$746K |
|
1938
Steven Madden
SHOO
$3.45B
| $7.15M | ﹤0.01% |
+229,724
| New | +$6.44M |
|
1939
CALL
HF Sinclair
DINO
$16.7B
| $7.14M | ﹤0.01% |
139,500
-25,500
| -15% | -$1.08M |
|
1940
Vera Bradley
VRA
$93M
| $7.14M | ﹤0.01% |
586,431
+114,210
| +24% | +$1.03M |
|
1941
Sherwin-Williams
SHW
$87.2B
| $7.13M | ﹤0.01% |
52,203
-1,003,560
| -95% | -$132M |
|
1942
PUT
HCA Healthcare
HCA
$87.6B
| $7.13M | ﹤0.01% |
81,200
+4,300
| +6% | +$345K |
|
1943
CALL
Goodyear
GT
$1.76B
| $7.12M | ﹤0.01% |
220,200
+35,300
| +19% | +$1.12M |
|
|
DBVT
1944
DBV Technologies
DBVT
$881M
| $7.11M | ﹤0.01% |
28,888
+10,522
| +57% | +$3.04M |
|
|
ALXN
1945
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $7.1M | ﹤0.01% |
59,400
-169,200
| -74% | -$20.6M |
|
1946
CALL
Prudential Financial
PRU
$43.2B
| $7.09M | ﹤0.01% |
61,700
-111,600
| -64% | -$12.5M |
|
1947
CALL
Nutanix
NTNX
$18B
| $7.09M | ﹤0.01% |
201,000
-65,100
| -24% | -$1.97M |
|
1948
Idexx Laboratories
IDXX
$43.4B
| $7.09M | ﹤0.01% |
45,313
+40,562
| +854% | +$6.38M |
|
1949
PUT
American Eagle Outfitters
AEO
$2.71B
| $7.09M | ﹤0.01% |
376,900
+96,400
| +34% | +$1.45M |
|
1950
COPT Defense Properties
CDP
$4.19B
| $7.08M | ﹤0.01% |
242,624
-275,791
| -53% | -$8.65M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.